Tidmarsh
FDA’s Pazdur Raises Concerns Over Legality of National Priority Voucher Program Amid Internal Disagreement
FDA; Pazdur; Commissioner’s National Priority Voucher; CNPV; legality; internal disagreement; tumor board; Tidmarsh; drug approval process